An analysis of the predictive probability of the in vitro contracture test for determining susceptibility to malignant hyperthermia

被引:18
|
作者
Hopkins, PM
Ellis, FR
Halsall, PJ
Stewart, AD
机构
[1] Malignant Hyperthermia Invest. Unit, St. James's University Hospital, Leeds
[2] Malignant Hyperthermia Invest. Unit, St. James's University Hospital
来源
ANESTHESIA AND ANALGESIA | 1997年 / 84卷 / 03期
关键词
D O I
10.1097/00000539-199703000-00034
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
An objective estimate of the likelihood of correct designation of malignant hyperthermia (MH) susceptibility from in vitro contracture test (IVCT) results is essential if genetic linkage studies of MPI are robe more informative. The aim of this study was to generate and test statistical models that could be used to predict the probability of susceptibility of an individual to MH from the results of their IVCTs. Logistic regression of the IVCT results of an index group of 50 patients (age range 9-73 years; MH susceptible [MHS], n = 13; MH normal [MHN], n = 32; MH equivocal [MHE], n = 5) who were either at low risk of MH or were proband cases were used to generate models to predict probability of MH susceptibility. Models incorporated data from individual contracture tests or from combinations of tests (static halothane, dynamic halothane, caffeine, ryanodine) performed according to the protocols of the European Malignant Hyperthermia Group. Of the individual contracture tests, the ryanodine test was most closely correlated with MH status. Discriminatory ability of the models was assessed using receiver operating characteristic (ROC) curves. Inclusion of predictor variables from the ryanodine, caffeine, and dynamic halothane tests improved upon the discriminatory ability of the models incorporating variables from individual tests and was considered to be the best model, The reproducibility of this model was confirmed using an ROC curve constructed using data from 47 patients (age range 10-62 years; MHS, n = 15; MHN, n = 28; MHE, n = 4) who were classified in a way similar to the index soup. A further group of 153 patients (age range 9-74 years; MHS, n = 44; MHN, n = 92; MHE, n = 17) who were consecutively tested relatives of susceptible individuals was used to assess the generalizability of the best model. The model met the criteria for a useful discriminatory model with this group of patients, 125 of whom (including 9 MHE patients) could be designated as positive or negative for MH with a likelihood of more than 95%. The logistic regression models provide objective likelihoods for the MPI phenotype that could be usefully incorporated into genetic linkage studies of the condition.
引用
收藏
页码:648 / 656
页数:9
相关论文
共 50 条
  • [41] Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility
    Wappler, F
    Anetseder, M
    Baur, CP
    Censier, K
    Doetsch, S
    Felleiter, P
    Fiege, M
    Fricker, R
    Halsall, PJ
    Hartung, E
    Heffron, JJA
    Heytens, L
    Hopkins, PM
    Klingler, W
    Lehmann-Horn, F
    Nivoche, Y
    Tegazzin, V
    Tzanova, I
    Urwyler, A
    Weisshorn, R
    Esch, JSA
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2003, 20 (07) : 528 - 536
  • [42] Diagnosis of malignant hyperthermia by in vitro contracture testing with the phosphodiesterase-III-inhibitor enoximone
    Fiege, M
    Wappler, F
    vonRichthofen, V
    Scholz, J
    Esch, JSA
    [J]. ANESTHESIOLOGY, 1997, 87 (03) : A364 - A364
  • [43] Malignant hyperthermia mutations and correlation with the severity of the anesthetic complication and the level of the in vitro contracture tests
    René Krivosic-Horber
    Anne-Frédérique Dalmas
    Etienne Brasdefer
    Nicole Monnier
    Valérie Deken
    [J]. BMC Anesthesiology, 14 (Suppl 1)
  • [44] NO RELATIONSHIP BETWEEN FIBER TYPE AND HALOTHANE CONTRACTURE TEST-RESULTS IN MALIGNANT HYPERTHERMIA
    HEIMANPATTERSON, T
    FLETCHER, JE
    ROSENBERG, H
    TAHMOUSH, AJ
    [J]. ANESTHESIOLOGY, 1987, 67 (01) : 82 - 84
  • [45] A COMPARISON OF THE CAFFEINE HALOTHANE MUSCLE CONTRACTURE TEST WITH THE MOLECULAR GENETIC DIAGNOSIS OF MALIGNANT HYPERTHERMIA
    MACKENZIE, AE
    ALLEN, G
    LAHEY, D
    CROSSAN, ML
    NOLAN, K
    METTLER, G
    WORTON, RG
    MACLENNAN, DH
    KORNELUK, R
    [J]. ANESTHESIOLOGY, 1991, 75 (01) : 4 - 8
  • [46] Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine:: a comparative investigation in malignant hyperthermia
    Bendahan, D
    Guis, S
    Monnier, N
    Kozak-Ribbens, G
    Lunardi, J
    Ghattas, B
    Mattei, JP
    Cozzone, PJ
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2004, 48 (08) : 1019 - 1027
  • [47] Multiminicore disease in a family susceptible to malignant hyperthermia - Histology, in vitro contracture tests, and genetic characterization
    Guis, S
    Figarella-Branger, D
    Monnier, N
    Bendahan, D
    Kozak-Ribbens, G
    Mattei, JP
    Lunardi, J
    Cozzone, PJ
    Pellissier, JF
    [J]. ARCHIVES OF NEUROLOGY, 2004, 61 (01) : 106 - 113
  • [48] Contractile elements in muscular fascial tissue - implications for in-vitro contracture testing for malignant hyperthermia
    Hoppe, K.
    Schleip, R.
    Lehmann-Horn, F.
    Jaeger, H.
    Klingler, W.
    [J]. ANAESTHESIA, 2014, 69 (09) : 1002 - 1008
  • [49] Identification of variants of the ryanodine receptor type 1 in patients with exertional heat stroke and positive response to the malignant hyperthermia in vitro contracture test
    Roux-Buisson, N.
    Monnier, N.
    Sagui, E.
    Abriat, A.
    Brosset, C.
    Bendahan, D.
    Kozak-Ribbens, G.
    Gazzola, S.
    Quesada, J. -L.
    Foutrier-Morello, C.
    Rendu, J.
    Figarella-Branger, D.
    Cozonne, P.
    Aubert, M.
    Bourdon, L.
    Lunardi, J.
    Faure, J.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2016, 116 (04) : 566 - 568
  • [50] RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes
    Robinson, RL
    Brooks, C
    Brown, SL
    Ellis, ER
    Halsall, PJ
    Quinnell, RJ
    Shaw, MA
    Hopkins, PM
    [J]. HUMAN MUTATION, 2002, 20 (02) : 88 - 97